These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 10747819)
1. In vitro antibacterial spectrum of a new broad-spectrum 8-methoxy fluoroquinolone, gatifloxacin. Fung-Tomc J; Minassian B; Kolek B; Washo T; Huczko E; Bonner D J Antimicrob Chemother; 2000 Apr; 45(4):437-46. PubMed ID: 10747819 [TBL] [Abstract][Full Text] [Related]
2. In vitro activity of BAY 12-8039, a new fluoroquinolone. Woodcock JM; Andrews JM; Boswell FJ; Brenwald NP; Wise R Antimicrob Agents Chemother; 1997 Jan; 41(1):101-6. PubMed ID: 8980763 [TBL] [Abstract][Full Text] [Related]
3. In-vitro activity of four new fluoroquinolones. García-Rodríguez JA; García Sánchez JE; García García MI; Fresnadillo MJ; Trujillano I; García Sánchez E J Antimicrob Chemother; 1994 Jul; 34(1):53-64. PubMed ID: 7961215 [TBL] [Abstract][Full Text] [Related]
4. The activity of the methylpiperazinyl fluoroquinolone CG 5501: a comparison with other fluoroquinolones. Wise R; Brenwald NP; Andrews JM; Boswell F J Antimicrob Chemother; 1997 Apr; 39(4):447-52. PubMed ID: 9145816 [TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activity of CS-940, a new trifluorinated quinolone. Biedenbach DJ; Sutton LD; Jones RN Antimicrob Agents Chemother; 1995 Oct; 39(10):2325-30. PubMed ID: 8619590 [TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone. Hosaka M; Yasue T; Fukuda H; Tomizawa H; Aoyama H; Hirai K Antimicrob Agents Chemother; 1992 Oct; 36(10):2108-17. PubMed ID: 1332587 [TBL] [Abstract][Full Text] [Related]
9. In-vitro activity of WIN 57273 compared to the activity of other fluoroquinolones and two beta-lactam antibiotics. Chin NX; Neu HC J Antimicrob Chemother; 1991 Jun; 27(6):781-91. PubMed ID: 1657856 [TBL] [Abstract][Full Text] [Related]
10. Antibacterial properties of AM-1155, a new 8-methoxy quinolone. Hosaka M; Kinoshita S; Toyama A; Otsuki M; Nishino T J Antimicrob Chemother; 1995 Aug; 36(2):293-301. PubMed ID: 8522459 [TBL] [Abstract][Full Text] [Related]
11. In vitro and in vivo evaluations of A-80556, a new fluoroquinolone. Clement JJ; Tanaka SK; Alder J; Vojtko C; Beyer J; Hensey D; Ramer N; McDaniel D; Chu DT Antimicrob Agents Chemother; 1994 May; 38(5):1071-8. PubMed ID: 8067740 [TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo activities of a new quinolone, WIN 57273, possessing potent activity against gram-positive bacteria. Sedlock DM; Dobson RA; Deuel DM; Lesher GY; Rake JB Antimicrob Agents Chemother; 1990 Apr; 34(4):568-75. PubMed ID: 2344163 [TBL] [Abstract][Full Text] [Related]
14. Comparative in-vitro activities of the new quinolone, Bay y 3118, and ciprofloxacin, sparfloxacin, tosufloxacin, CI-960 and CI-990. Bauernfeind A J Antimicrob Chemother; 1993 Apr; 31(4):505-22. PubMed ID: 7605398 [TBL] [Abstract][Full Text] [Related]
15. E-4695, a new C-7 azetidinyl fluoronaphthyridine with enhanced activity against gram-positive and anaerobic pathogens. Guinea J; Gargallo-Viola D; Robert M; Tudela E; Xicota MA; Garcia J; Esteve M; Coll R; Pares M; Roser R Antimicrob Agents Chemother; 1995 Feb; 39(2):413-21. PubMed ID: 7726507 [TBL] [Abstract][Full Text] [Related]
16. In vitro activities of PD 117,596 and reference antibiotics against 448 clinical bacterial strains. Smith RP; Baltch AL; Hammer MC; Conroy JV Antimicrob Agents Chemother; 1988 Sep; 32(9):1450-5. PubMed ID: 3196008 [TBL] [Abstract][Full Text] [Related]
17. Antibacterial activities of grepafloxacin, ciprofloxacin, ofloxacin and fleroxacin. Barry AL; Fuchs PC J Chemother; 1997 Feb; 9(1):9-16. PubMed ID: 9106012 [TBL] [Abstract][Full Text] [Related]
18. The comparative in-vitro activity of eight newer quinolones and nalidixic acid. King A; Phillips I J Antimicrob Chemother; 1986 Nov; 18 Suppl D():1-20. PubMed ID: 3468100 [TBL] [Abstract][Full Text] [Related]
19. In vitro antimicrobial activity of gatifloxacin compared with other quinolones against clinical isolates from cancer patients. Rolston KV; Vaziri I; Frisbee-Hume S; Streeter H; LeBlanc B Chemotherapy; 2004 Nov; 50(5):214-20. PubMed ID: 15523180 [TBL] [Abstract][Full Text] [Related]
20. In vitro activity of gemifloxacin against a broad range of recent clinical isolates from the USA. McCloskey L; Moore T; Niconovich N; Donald B; Broskey J; Jakielaszek C; Rittenhouse S; Coleman K J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():13-21. PubMed ID: 10824027 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]